The CDC narrows the use of the J&J vaccine due to concerns about rare blood clots
The blood-clotting problem, known as TTS, has been seen at a rate of about one case in every 100,000 doses given to women 30 to 49 years old — the group at highest risk.
The blood-clotting problem, known as TTS, has been seen at a rate of about one case in every 100,000 doses given to women 30 to 49 years old — the group at highest risk.
You received this message because you're subscribed to Breaking News Alerts emails. This email was sent by National Public Radio, Inc., 1111 North Capitol Street NE, Washington, DC 20002
No comments:
Post a Comment